Navigation Links
Safeway gives another $317,000 for TGen breast cancer research
Date:2/16/2010

PHOENIX, Ariz. Feb. 16, 2010 Even with unemployment high and sales down, Safeway Inc. has donated more than $317,000 to fund breast cancer research at the Translational Genomics Research Institute (TGen).

Donations raised in October during Breast Cancer Awareness Month increased the total contributions by Safeway to TGen over the past three years to more than $1.5 million, said Michael Bassoff, president of the non-profit TGen Foundation.

"I'm very grateful that Safeway leadership Safeway management is able to make all of this possible. We have so much to thank you for,'' Bassoff told Dan Valenzuela, President of Safeway's Phoenix Division, which includes 115 stores across Arizona.

Valenzuela said that even in this challenging economic environment, Safeway's customers and employees succeeded in providing TGen with needed funds to find new treatments for breast cancer patients.

"It's been a challenging year for us. Everybody has hardships that they see within their own families or among their friends,'' Valenzuela said. "It's great to see all these people at TGen coming together and working towards a common goal. It's very impressive, and it's an honor to be a part of it. It's a great partnership, because TGen is a local organization, here in our own state, and we can see the benefits of their scientists' hard work."

Because of the economy, Valenzuela said, Safeway is working harder than ever to help fund the needs of local organizations: "We have more people than ever before that we are trying to help, especially in a tough economy. There are a lot of great organizations out there, and there are a lot of people who need more help than ever before. You want to help everybody."

Dr. Heather Cunliffe, head of TGen's Breast and Ovarian Cancer Research Unit, said that, thanks to Safeway, TGen scientists are making significant progress in three key areas of breast cancer research:

  • Accelerating an understanding of genetic events that contribute to, and prevent the onset of, breast cancer.

  • Discovering new cellular mechanics that drive the spread of breast cancer cells to distant organs, which can be targeted through novel therapeutic approaches.

  • Conducting high-resolution genomic tests of breast tumor biopsy material, providing better guidance for oncologists and resulting in optimized disease management for breast cancer patients.

"We are extremely proud to be partnering with Safeway, which is enabling these significant accomplishments within a short time frame. Your contributions are truly astonishing," Cunliffe told Valenzuela. "Your customers and employees are certainly crusaders in the war on breast cancer."


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Safeway gives $685,000 to TGen for breast cancer research
2. Safeway Inc. and PCF to fund landmark prostate cancer research collaboration
3. New forensic technique gives clues about sharks from bite damage
4. Skin color gives clues to health
5. K-State lab gives researchers the tools to study porcine circovirus associated diseases
6. New theory gives more precise estimates of large-scale biodiversity
7. Ovarian transplantation: New technique gives greatly improved results in this delicate operation
8. Shock and kill research gives new hope for HIV-1 eradication
9. Breast health center gives TGen new research opportunities
10. New method developed by UC San Diego bioengineers gives regenerative medicine a boost
11. Cancer Genomics Browser gives cancer researchers a powerful new tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm Reports ... the laboratory use of nuclear magnetic resonance spectroscopy ... end-users and profiled current practices, developments, trends and ... well as growth and opportunities. These areas include ... NMR instruments, needs and innovation requirements, hyphenated NMR ...
(Date:1/19/2017)... January 19, 2017 According to a new report published ... 2014 - 2022," the global biometric sensor market is expected to garner $1.5 ... In 2015, Asia-Pacific dominated the global market and contributed ... Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; ... Friday, February 24, 2017 a total of 10,672,750 common share ... per common share. Proceeds from the exercise of these warrants ... Treasury.   ... "We are grateful for this expression of confidence by our ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences ... Spain has been appointed as a Certified ... The IsoFlux system will be used in Genetracer Biotech,s ... to lung and colon cancer, with plans to move ... laboratory is utilizing Fluxion,s IsoFlux System to isolate, recover, ...
(Date:2/25/2017)... , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change by ... and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. , ...
(Date:2/24/2017)... Feb. 24, 2017 Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... to participate in its previously announced rights offering ... shares of common stock and Series C Convertible ... listed warrants. As previously announced, ...
Breaking Biology Technology: